avb: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Net income	890,614	506,452	236,597	800,083
Depreciation expense	679,989	449,618	217,888	631,314
Amortization of deferred financing costs and debt discount	10,173	6,280	3,233	9,995
Loss on extinguishment of debt, net	-	-	-	0
Amortization of stock-based compensation	21,268	14,119	5,662	20,241
Equity in (income) loss of, and return on, unconsolidated investments and noncontrolling interests, net of eliminations	-	-	-	27,290
Equity in income of, and return on, unconsolidated investments and noncontrolling interests, net of eliminations	-32,994	6,666	3,093	-
Casualty and impairment loss	858	858	0	1,415
Expensed transaction, development and other pursuit costs, net of recoveries	8,629	7,237	4,744	7,235
Cash flow hedge gains reclassified to earnings	912	843	273	197
Gain on sale of real estate assets, net	340,150	159,786	56,660	242,032
Increase in prepaid expenses and other assets	35,365	35,869	8,963	32,965
Increase in accrued expenses, other liabilities, accrued interest payable and resident security deposits	68,564	-1,017	10,582	111,266
Net cash provided by operating activities	1,270,674	793,715	415,903	1,279,065
Development/redevelopment of real estate assets including land acquisitions and deferred development costs	849,799	549,366	237,282	691,744
Acquisition of real estate assets, including partnership interest	643,975	384,495	187,362	278,363
Capital expenditures - existing real estate assets	183,809	109,039	48,370	136,431
Capital expenditures - non-real estate assets	2,509	1,875	256	4,554
Increase (decrease) in payables for construction	11,951	15,665	-3,400	-6,440
Proceeds from sale of real estate, net of selling costs	799,247	228,058	63,651	502,808
Note receivable lending	20,327	15,630	12,560	65,913
Note receivable payments	25	25	109	237
Distributions from unconsolidated entities and investment sale proceeds	0	-	-	7,178
Unconsolidated investments	35,881	6,553	2,395	9,367
Net cash used in investing activities	-925,077	-823,210	-427,865	-682,589
Issuance of common stock, net	3,377	3,377	693	7,232
Repurchase of common stock, net	151,846	-	-	0
Dividends paid	742,879	492,646	243,678	720,136
Net borrowings under unsecured credit facility and commercial paper	234,981	665,000	224,942	0
Repayments of mortgage notes payable, including prepayment penalties	10,492	9,430	1,171	9,131
Issuance of unsecured notes	947,488	450,000	-	398,788
Repayment of unsecured notes	525,000	525,000	-	0
Payment of deferred financing costs	20,003	15,966	0	3,762
Receipt for termination of forward interest rate swaps	-4,099	0	-	-16,839
Payments related to tax withholding for share-based compensation	16,643	16,544	16,353	16,602
Noncontrolling interests, joint venture and preferred equity transactions	13,864	1,000	440	8,187
Net cash used in financing activities	-290,782	57,791	-36,007	-334,959
Net increase in cash, cash equivalents and restricted cash	54,815	28,296	-47,969	261,517
Cash and cash equivalents at beginning of period	267,076	267,076	267,076	530,960
Cash and cash equivalents at end of period	321,891	295,372	219,107	792,477

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

avb: the cashflow